首页 产品目录 分子砌块 按官能团 烯烃 (3aR,5R,7S,8S,9R,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-hydroxyacetate

(3aR,5R,7S,8S,9R,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-hydroxyacetate

(3aR,5R,7S,8S,9R,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-hydroxyacetate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5g 95% 询价
- +
25g 95% 询价
- +
100g 95% 询价
- +
500g 95% 询价
- +
1kg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

125-65-5

英文名称

(3aR,5R,7S,8S,9R,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-hydroxyacetate

别名

PLEUROMULIN;PLEUROMUTILIN;a4014c;antibioticbc757;bc757;drosopholinb;glycolicacid,8-esterwithoctahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-6-viny;l-3a,9-propano-3ah-cyclopentacycloocten-1(4h)-one

标准英文名

(3aR,5R,7S,8S,9R,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-hydroxyacetate

分子式

C22H34O5

分子量

378.51

精确分子量

378.24

SMILES

C=C[C@]1(C)C[C@@H](OC(=O)CO)C2(C)[C@H](C)CCC3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O

标准SMILES

CC12[C@@H]3C(=O)CCC3(CC[C@H]1C)[C@@H](C)[C@H](O)[C@@](C)(C[C@H]2OC(=O)CO)C=C

用途

Pleuromutilin is a tricyclic diterpenoid antibiotic that serves as the precursor for semisynthetic pleuromutilin derivatives. It exhibits broad-spectrum antibacterial activity against most Gram-positive bacteria, mycoplasmas, and some Gram-negative bacteria by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit and suppressing peptidyl transferase activity. Pleuromutilin derivatives have been developed for both veterinary and human use: - Tiamulin and valnemulin are used exclusively in veterinary medicine for treating swine dysentery, pneumonia, and other respiratory and gastrointestinal infections in livestock and poultry; valnemulin is particularly effective for mycoplasma-induced pulmonary diseases due to its high lung concentration. - Retapamulin is approved for human topical use in treating impetigo caused by Staphylococcus aureus and Streptococcus pyogenes in adults and children aged 9 months and older. - Lefamulin (BC-3781), a novel pleuromutilin derivative, is under development as the first systemic (intravenous or oral) pleuromutilin antibiotic for human use, intended for the treatment of community-acquired bacterial pneumonia (CABP).

InChIKey

ZRZNJUXESFHSIO-JKZASVEESA-N

安全信息

SureRoute逆合成路线

1.  125-65-5 逆合成路线 1

—
—
ACSZEH342
125-65-5
来源: SureRoute

2.  125-65-5 逆合成路线 2

—
—
ACSZEH342
125-65-5
来源: SureRoute

3.  125-65-5 逆合成路线 3

—
—
ACBXCF471
2836-32-0
ACSZEH342
125-65-5
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手